Literature DB >> 22761462

Long-term cognitive impairments and attentional deficits in patients with Cushing's disease and cortisol-producing adrenal adenoma in remission.

Oskar Ragnarsson1, Peter Berglund, Derek N Eder, Gudmundur Johannsson.   

Abstract

CONTEXT: Cognitive function is impaired in patients with active Cushing's syndrome (CS).
OBJECTIVE: The aim was to study cognitive function in patients with CS in long-term remission.
DESIGN: We conducted a cross-sectional, case-controlled, single center study. PATIENTS: Fifty-five patients previously treated for Cushing's disease (n = 43) and cortisol-producing adrenal adenoma (n = 12) and 55 controls matched for age, gender, and educational level participated in the study.
METHODS: Working memory, attention, information-processing speed, verbal fluency, and reading speed were studied using standardized neuropsychological testing and alerting, orienting, and executive control using the Attentional Network Test. Fatigue impact scale and the comprehensive psychopathological rating scale were used to evaluate fatigue and affective disorder.
RESULTS: Median (interquartile range) duration of remission was 13 (5-19) yr and the mean ± SD age at follow-up was 54 ± 14 yr. Compared to controls, patients had a higher score on the fatigue impact scale, indicating greater burdens of fatigue, and a higher score on the comprehensive psychopathological rating scale subscales for depression and anxiety. In a multivariate analysis, attention, spatial orienting, alerting, working memory, verbal fluency, and reading speed were all diminished in comparison to controls, independent of scores for affective disorder and fatigue. No overall difference in outcome was seen between patients in long-term remission for Cushing's disease and cortisol-producing adrenal adenoma.
CONCLUSION: Patients with CS in remission have impaired cognitive function that cannot be explained by the coexistence of affective disorder or chronic fatigue. The pattern of cognitive and attentional deficits suggests a more global involvement of the brain function than has previously been suggested.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22761462     DOI: 10.1210/jc.2012-1945

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  25 in total

1.  Computerized Analysis of Brain MRI Parameter Dynamics in Young Patients With Cushing Syndrome-A Case-Control Study.

Authors:  Amit Tirosh; Harish RaviPrakash; Georgios Z Papadakis; Christina Tatsi; Elena Belyavskaya; Lyssikatos Charalampos; Maya B Lodish; Ulas Bagci; Constantine A Stratakis
Journal:  J Clin Endocrinol Metab       Date:  2020-05-01       Impact factor: 5.958

Review 2.  The Treatment of Cushing's Disease.

Authors:  Rosario Pivonello; Monica De Leo; Alessia Cozzolino; Annamaria Colao
Journal:  Endocr Rev       Date:  2015-06-11       Impact factor: 19.871

Review 3.  Psychiatric Symptoms in Patients with Cushing's Syndrome: Prevalence, Diagnosis and Management.

Authors:  Alicia Santos; Eugenia Resmini; Juan Carlos Pascual; Iris Crespo; Susan M Webb
Journal:  Drugs       Date:  2017-05       Impact factor: 9.546

4.  Treatment of Cushing's Syndrome: An Endocrine Society Clinical Practice Guideline.

Authors:  Lynnette K Nieman; Beverly M K Biller; James W Findling; M Hassan Murad; John Newell-Price; Martin O Savage; Antoine Tabarin
Journal:  J Clin Endocrinol Metab       Date:  2015-07-29       Impact factor: 5.958

Review 5.  Cushing's disease: the burden of illness.

Authors:  Rosario Pivonello; Maria Cristina De Martino; Monica De Leo; Chiara Simeoli; Annamaria Colao
Journal:  Endocrine       Date:  2016-05-17       Impact factor: 3.633

6.  Cases of Psychiatric Morbidity in Pediatric Patients After Remission of Cushing Syndrome.

Authors:  Margaret F Keil; Alan Zametkin; Celia Ryder; Maya Lodish; Constantine A Stratakis
Journal:  Pediatrics       Date:  2016-03-29       Impact factor: 7.124

Review 7.  Dynamic changes of views on the brain changes of Cushing's syndrome using different computer-assisted tool.

Authors:  Lu Gao; Lu Liu; Lin Shi; Yishan Luo; Zihao Wang; Xiaopeng Guo; Bing Xing
Journal:  Rev Endocr Metab Disord       Date:  2020-03       Impact factor: 6.514

8.  Hormone levels are related to functional compensation in prolactinomas: A resting-state fMRI study.

Authors:  Shun Yao; Pan Lin; Matthew Vera; Farhana Akter; Ru-Yuan Zhang; Ailiang Zeng; Alexandra J Golby; Guozheng Xu; Yanmei Tie; Jian Song
Journal:  J Neurol Sci       Date:  2020-02-01       Impact factor: 3.181

9.  Congenital Adrenal Hyperplasia Due to Steroid 21-Hydroxylase Deficiency: An Endocrine Society Clinical Practice Guideline.

Authors:  Phyllis W Speiser; Wiebke Arlt; Richard J Auchus; Laurence S Baskin; Gerard S Conway; Deborah P Merke; Heino F L Meyer-Bahlburg; Walter L Miller; M Hassan Murad; Sharon E Oberfield; Perrin C White
Journal:  J Clin Endocrinol Metab       Date:  2018-11-01       Impact factor: 5.958

Review 10.  Endocrine risk factors for COVID-19: Endogenous and exogenous glucocorticoid excess.

Authors:  Frederick Vogel; Martin Reincke
Journal:  Rev Endocr Metab Disord       Date:  2021-07-09       Impact factor: 6.514

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.